CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀüÈ«Àç
  • ¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °£¾Ï/Ãé´ãµµ¾Ï
  • Á÷ À§: ºÎ±³¼ö(¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
35 ÇØ¿Ü STING signaling has a favorable clinical implication in colorectal cancer (CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, New York, United States, 2018)  
34 ÇØ¿Ü Management of biliary cancer: metastatic disease (The 27th Clinical Trial Education Workshop, Seoul, Korea, 2018)  
33 ÇØ¿Ü An oral dual inhibitor of IDO and TDO enhances anti-cancer immunity and synergizes with immune checkpoint blockade (ESMO 2018, Munich, Germany)  
32 ÇØ¿Ü STING, an immune biomarker for colorectal cancer (ESMO Asia 2018, Singapore)  
31 ÇØ¿Ü Current evidence and future perspective of immunotherapy in HCC (HCC Symposium, KSMO, Seoul, Korea, 2018)  
30 ÇØ¿Ü Multicenter Retrospective Analysis for Efficacy and Safety of Liposomal Irinotecan plus 5-FU/leucovorin (5-FU/LV) after Progression on Gemcitabine-based therapy in Korean Patients with Metastatic Pancreatic Ductal Adenocarcinoma: A Study by Korean Cancer Study Group (Gastrointestinal Cancer Symposium, San Francisco, CA, United States, 2019)  
29 ÇØ¿Ü Intratumoral high endothelial venules as a surrogate marker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer (AACR Annual Meeting, Atlanta, Georgia, United States, 2019)  
28 ÇØ¿Ü Intratumoral STING activation normalizes tumor vasculatures and synergizes with anti-angiogenic therapy to enhance cancer immunity (AACR Annual Meeting, Atlanta, Georgia, United States, 2019)  
27 ÇØ¿Ü New standard therapy in advanced pancreatic cancer (Luncheon Symposium, 17th Annual Symposium & General Assembly, Seoul, Korea, 2019)  
26 ÇØ¿Ü Optimal timing for systemic chemotherapy in TACE refractory HCC patients (HCC Symposium, KSMO, Seoul, Korea, 2019)  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729